Please login to the form below

Not currently logged in
Email:
Password:

S-A and Boehringer team up for AF campaign

Sanofi-aventis and Boehringer Ingelheim are to work with the World Heart Federation to raise awareness of atrial fibrillation
The World Heart Federation, sanofi-aventis (S-A) and Boehringer Ingelheim are to collaborate on the AF AWARE (Atrial Fibrillation Awareness And Risk Education) campaign to raise awareness of atrial fibrillation (AF) and its links to severe consequences including cardiovascular (CV) mortality, stroke and CV hospitalisations. 

The campaign aims to promote education around the risks associated with AF, as well as highlight the importance of early diagnosis and comprehensive management to maximise patient outcomes.

Johanna Ralston, CEO of the World Heart Federation, said: "The AF AWARE campaign was established to specifically address the lack of awareness and endeavours to draw attention to this serious, chronic, disease, the consequences of which can have devastating effects on patients and healthcare systems."

The World Heart Federation will lead the initiative internationally and will also work closely with the Stroke Alliance for Europe and the Atrial Fibrillation Association to deliver the programme. 

Agreements have been established with sanofi-aventis and Boehringer Ingelheim for a co-sponsorship, with both companies providing funding for the campaign.

15th February 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics